Laboratory Medicine

Test Directory / Anti-NMDA receptor Antibodies

Anti-NMDA receptor Antibodies

Brown clotted serum, gel barrier

Test	Anti-NMDA receptor Antibodies
Common Abbreviations	NMDA
Profile	N/A
Clinical Indication	N-methyl-D-aspartate (NMDA) receptor antibodies are associated with the different sub units of the NMDA receptor. Antibodies to the delta or NR2 subunits of NMDA receptor are associated with limbic encephalitis, systemic lupus erythematosus (SLE), ataxia and epilepsia partialis continua. Antibodies against the NR1, NR2A and NR2B subunits of the NMDA are found in patients presenting with psychiatric symptoms, amnesia, seizures, dyskinesias, autonomic dysfunction and loss of consciousness.
Specimen Type	Blood
Sample Type	Serum (can be paired with CSF sample)
Minimum Volume	0.5 mL
Special Precautions	No special requirements
Stability	Contact Referral Laboratory
Turnaround Time	3 weeks
Laboratory	Immunology Laboratory, Oxford University Hospitals NHSFT
Reference Interval	Contact Referral Laboratory
Limitations	Contact Referral Laboratory

Update for visitors

Visiting restrictions are in place at our hospitals to stop the spread of norovirus. These restrictions will be in place until further notice.

The following wards are closed to visitors:

York Hospital: Ward 29 and Ward 37.

There are four exceptions only to the restrictions. These are:

For patients who are receiving end of life care

Paediatric patients (babies and children)

Maternity care

The family carers of those with dementia

We understand these restrictions can be difficult when a loved one is unwell. The restrictions will be reviewed daily and lifted as soon as it is safe. Thank you for your understanding as we try to reduce the spread of norovirus in our hospitals.